Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

Recruiting now · Phase 3

Conditions studied: Acquired Fibrinogen Deficiency

In brief

This study is a phase 3, prospective, single center, randomized, open label, controlled, parallel arm, interventional study to investigate the efficacy and safety of CSL511, in participants undergoing cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei (PMP) with predicted intraoperative blood loss of greater than or equal to (\>=) 2 liter (L). Eligible participants will be randomized in a 1:1 ratio to 1 of 2 treatment arms, to receive CSL511 or cryoprecipitate.

Key facts

Study ID

NCT06617897

Run by

CSL Behring

People needed

90

Starts

2024-10-01

Expected to finish

2027-10-29

Last updated by the study team

2026-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• • Aged >= 18 years at the time of providing written informed consent.
• • Diagnosis of PMP requiring CRS with HIPEC.
• • Bleeding risk: Predicted intraoperative blood loss of >=2L, assessed within 60 and 100 mins after start of study surgery (assessment made before 2 L of blood is lost)

You may not qualify if…

• • Confirmed or suspected congenital or acquired coagulation disorder or a prothrombotic disorder
• • Myocardial infarction, acute coronary syndrome, or stroke within 2 months before study surgery.
• • Known history of chronic hepatitis.
• • Clopidogrel or ticagrelor administration within 5 days before study surgery.
• • Prasugrel administration within 7 days before study surgery.
• • Oral factor Xa inhibitor administration within 2 days before study surgery.
• • Glycoprotein IIb / IIIa antagonist administration within 24 hours before study surgery.
• • Oral direct thrombin inhibitor administration within 3 days before study surgery.
• • Vitamin K antagonists within 5 days before study surgery.

Where it is running

• Basingstoke and North Hampshire Hospital — Basingstoke, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.